[HTML][HTML] Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial

TH Kim, YH Koh, BH Kim, MJ Kim, JH Lee, B Park… - Journal of …, 2021 - Elsevier
Background & Aims Proton beam radiotherapy (PBT) has recently been applied to treat
hepatocellular carcinoma (HCC); however, there is no randomized controlled trial-based …

[引用][C] Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial

TH Kim, YH Koh, BH Kim, MJ Kim, JH Lee, B Park… - Journal of …, 2021 - cir.nii.ac.jp
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular
carcinoma: A randomized phase III trial | CiNii Research CiNii 国立情報学研究所 学術情報 …

Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.

TH Kim, YH Koh, BH Kim, MJ Kim, JH Lee… - Journal of …, 2020 - europepmc.org
Methods Patients with rHCC (size< 3 cm, number≤ 2) were randomly assigned to receive
PBT or RFA according to Child-Pugh score and tumor stage. After randomization, if the …

[HTML][HTML] Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial

TH Kim, YH Koh, BH Kim, MJ Kim… - Journal of …, 2021 - journal-of-hepatology.eu
Background & Aims Proton beam radiotherapy (PBT) has recently been applied to treat
hepatocellular carcinoma (HCC); however, there is no randomized controlled trial-based …

Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial

TH Kim, YH Koh, BH Kim, MJ Kim… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background & aims Proton beam radiotherapy (PBT) has recently been applied to treat
hepatocellular carcinoma (HCC); however, there is no randomized controlled trial-based …

Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial

TH Kim, YH Koh, BH Kim, MJ Kim, JH Lee, B Park… - journal-of-hepatology.eu
Lencioni et al.[1] 2003 Phase III 54 96†(2yr)-Lin et al.[2] 2005 Phase III 70 86†(2yr)/86†(3yr)
4.8 Nakazawa et al.[3] 2007 Retrospective 85 87†(3yr) 0 Choi et al.[4] 2007 Retrospective …